Stereotaxis, Inc. (NASDAQ:STXS)

CAPS Rating: 3 out of 5

The Company designs, manufactures and markets an advanced cardiology instrument control system for use in a hospital's interventional surgical suite, or cath lab.

Recs

0
Player Avatar screach (81.75) Submitted: 2/16/2010 12:27:28 PM : Outperform Start Price: $4.77 STXS Score: -114.89

Best product in the category, even with the high initial cost to hospitals. Adoption is growing.

Featured Broker Partners


Advertisement